// App-Quantinova.ai

4215 : Hyperpolarized magnetic resonance metabolic imaging and NMR metabolomics to assess the progression and aggressiveness of patient-derived pancreatic cancer xenografts

Researchers

Presenter

  • Prasanta Dutta

Principal Investigators

  • Mayrim Rios Perez

  • Travis Cole Salzillo

  • Michael Pratt

  • Yaan Kang

  • Niki Zacharias

  • Anirban Maitra

  • Jason B. Fleming

  • Pratip Bhattacharya

Medical Centers

  • MD Anderson Cancer Center, HOUSTON, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Choline bitartrate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A